|
May 9
|
Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year?
|
|
May 9
|
Ligand Pharmaceuticals First Quarter 2024 Earnings: EPS: US$4.86 (vs US$2.56 in 1Q 2023)
|
|
May 9
|
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
|
|
May 8
|
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
|
|
May 8
|
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
|
|
May 8
|
Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates
|
|
May 8
|
Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues
|
|
May 8
|
Ligand Pharmaceuticals Inc (LGND) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ...
|
|
May 8
|
Agenus Inc (AGEN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...
|
|
May 8
|
Q1 2024 Agenus Inc Earnings Call
|
|
May 7
|
Ligand Pharmaceuticals Inc (LGND) Reports Mixed Q1 2024 Results: Misses Revenue Estimates but ...
|
|
May 7
|
Agenus (AGEN) Q1 2024 Earnings Call Transcript
|
|
May 7
|
Ligand Pharmaceuticals (LGND) Tops Q1 Earnings Estimates
|
|
May 7
|
Ligand Reports First Quarter 2024 Financial Results
|
|
May 7
|
Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil
|
|
May 7
|
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
|
|
May 7
|
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
|
|
May 7
|
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
|
|
May 6
|
Don't Overlook These Top Medical Stocks as Q1 Earnings Approach
|